MedPath
NMPA Approval

Surufatinib Capsules

国药准字H20217028

April 8, 2021

国药准字H20200017

Drug Information

索凡替尼胶囊

苏泰达/Sulanda

胶囊剂

100mg

化学药品

April 8, 2021

Company Information

Applicant Company

中国(上海)自由贸易试验区蔡伦路720弄4号

Manufacturing Company

江苏省苏州市苏州工业园区东平街188号C32栋

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

索凡替尼胶囊 - NMPA 批准文号 | MedPath